Pub. Date : 2017 Jun
PMID : 28399721
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The newest agent targeting the prostacyclin pathway, the selective prostacyclin receptor agonist selexipag, is administered orally, and has been shown to reduce a composite morbidity/mortality endpoint. | selexipag | prostaglandin I2 receptor | Homo sapiens |